Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q2 2024 Orthopedics Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q2 2024 Orthopedics Update

From a deal count perspective, orthopedic M&A activity slowed in Q2 2024 despite the momentum seen in 2023 and Q1 2024. However, the industry remains highly fragmented and ripe for consolidation, with strong investor appetite continuing to drive interest. Traditional PE platforms and health systems are now facing increased competition for acquisitions due to the rise in activity from historically ASC-focused operators like SCA, Surgery Partners, and USPI, who are becoming more active in the orthopedic practice management space. These strategic acquirers can offer an attractive alternative to traditional buyers like health systems or PE-backed platforms, while providing similar levels of autonomy to that of private equity, but a more certain path to a second liquidity event.

Provident expects robust M&A activity through the remainder of 2024 and throughout 2025, with several sponsors nearing the end of their typical investment hold periods and several large orthopedic mandates on the market progressing towards a close.

To print and download the full Orthopedics Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/07/Q2-2024-Orthopedics-vF.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]